| Age at diagnosis (mean, sd) |
40 years, 9.8 |
| Sex |
20 men (55.5%); 16 female (45.5%) |
| Habitation |
28 urban (78%); 8 rural (22%) |
| Initial clinical symptoms and signs |
|
| Headache |
28 (77.8%) |
| Nausea/vomiting |
21 (58.3%) |
| Seizures |
16 (44.4%) |
| Fatigue |
8 (22.2%) |
| Papilledema |
17 (47.2%) |
| Motor deficits |
8 (22.2%) |
| Meningeal irritation |
7 (19.4%) |
| Cranial nerve deficits |
5 (13.9%) |
| Cognitive impairment |
4 (11.1%) |
| Ataxia/dysmetria |
2 (5.6%) |
| Initial clinical syndromes |
|
| Raised intracranial pressures |
21 (58.3%) |
| Seizures |
16 (44.4%) |
| Headache (w/o raised intracranial pressure) |
9 (25%) |
| Cysticercotic meningitis |
7 (19.4%) |
| Clinical syndromes during all the follow-up period |
|
| Raised intracranial pressure |
27 (75%) |
| Cysticercotic meningitis |
26 (72.2%) |
| Seizures |
22 (61.1%) |
| Headache (w/o raised intracranial pressure) |
18 (50%) |
| Treatment modalities |
|
| Anti-parasitic drugs |
22 (61.1%) |
| Corticosteroids |
28 (77.8%) |
| Ventriculoperitoneal shunt |
23 (63.9%) |
| Microsurgical removal of cysts |
7 (19.4%) |
| Endoscopic approaches |
7 (19.4%) |
